Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.510
0.00 (0.00%)
At close: Aug 5, 2026, 4:00 PM EDT
1.470
-0.040 (-2.65%)
After-hours: Aug 5, 2026, 7:34 PM EDT
Co-Diagnostics Employees
Co-Diagnostics had 115 employees as of December 31, 2025. The number of employees decreased by 17 or -12.88% compared to the previous year.
Employees
115
Change (1Y)
-17
Growth (1Y)
-12.88%
Revenue / Employee
$6,245
Profits / Employee
-$421,763
Market Cap
7.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 115 | -17 | -12.88% |
| Dec 31, 2024 | 132 | -23 | -14.84% |
| Dec 31, 2023 | 155 | 10 | 6.90% |
| Dec 31, 2022 | 145 | 44 | 43.56% |
| Dec 31, 2021 | 101 | 62 | 158.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| Picard Medical | 75 |
| IceCure Medical | 69 |
| VolitionRx | 67 |
| Modular Medical | 51 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
| HeartSciences | 14 |
CODX News
- 6 days ago - Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast - PRNewsWire
- 8 days ago - Co-Diagnostics joint venture CoSara provides ebola test kits for India studies - TheFly
- 8 days ago - Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies - PRNewsWire
- 14 days ago - Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform - PRNewsWire
- 15 days ago - Co-Diagnostics Proxy statement: Proxy filing - Filings
- 20 days ago - Co-Diagnostics appoints Wes Lindsey as Chief Scientific Officer - TheFly
- 20 days ago - Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer - PRNewsWire
- 26 days ago - Co-Diagnostics Proxy statement: Proxy filing - Filings